| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.78B | 42.91B | 36.11B | 37.67B | 35.92B | 36.93B |
| Gross Profit | 15.37B | 14.88B | 10.61B | 12.15B | 12.67B | 12.20B |
| EBITDA | 10.38B | 10.00B | 6.29B | 8.12B | 9.29B | 7.87B |
| Net Income | 4.88B | 4.48B | 2.12B | 3.40B | 4.46B | 4.32B |
Balance Sheet | ||||||
| Total Assets | 65.58B | 66.61B | 62.51B | 61.37B | 59.13B | 56.75B |
| Cash, Cash Equivalents and Short-Term Investments | 6.63B | 8.06B | 8.26B | 8.11B | 8.33B | 4.62B |
| Total Debt | 359.00M | 561.00M | 1.55B | 1.48B | 1.55B | 1.46B |
| Total Liabilities | 17.88B | 19.14B | 18.53B | 18.44B | 18.63B | 19.46B |
| Stockholders Equity | 47.70B | 47.46B | 43.97B | 42.92B | 40.50B | 37.28B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.83B | 1.66B | 2.50B | 5.13B | 865.00M |
| Operating Cash Flow | 0.00 | 8.66B | 4.99B | 5.17B | 9.11B | 6.79B |
| Investing Cash Flow | 0.00 | -6.54B | -3.09B | -3.55B | -3.93B | -5.82B |
| Financing Cash Flow | 0.00 | -2.36B | -1.79B | -1.90B | -1.46B | -1.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥165.51B | 9.78 | 10.24% | 2.43% | 6.08% | 8.55% | |
77 Outperform | ¥731.81B | 3.29 | 27.58% | 0.99% | 9.49% | 55.64% | |
75 Outperform | ¥117.48B | 15.30 | ― | 1.79% | 10.76% | 54.82% | |
72 Outperform | ¥13.52B | 4.54 | ― | 4.80% | 4.49% | 26.84% | |
66 Neutral | ¥137.07B | 17.53 | 2.80% | 3.38% | >-0.01% | -49.83% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥1.58T | 117.21 | 3.37% | 1.85% | -2.18% | 26.45% |